Traditionally, according to the pathologic criteria, BC has been broadly grouped into three categories based on the expression of hormone receptors (estrogen and progesterone) (HR) and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene NR4A1 and breast cancer.